{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T09:11:44Z","timestamp":1770455504687,"version":"3.49.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Inf Sci Syst"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1007\/s13755-020-00134-4","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T11:03:30Z","timestamp":1610535810000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["GLIMPSE: a glioblastoma prognostication model using ensemble learning\u2014a surveillance, epidemiology, and end results study"],"prefix":"10.1007","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8536-6495","authenticated-orcid":false,"given":"Kamel A.","family":"Samara","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2285-953X","authenticated-orcid":false,"given":"Zaher","family":"Al Aghbari","sequence":"additional","affiliation":[]},{"given":"Amani","family":"Abusafia","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"134_CR1","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jclinepi.2015.10.002","volume":"71","author":"F Bagherzadeh-Khiabani","year":"2016","unstructured":"Bagherzadeh-Khiabani F, et al. A tutorial on variable selection for clinical prediction models: feature selection methods in data mining could improve the results. J Clin Epidemiol. 2016;71:76\u201385. https:\/\/doi.org\/10.1016\/j.jclinepi.2015.10.002.","journal-title":"J Clin Epidemiol"},{"key":"134_CR2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.wneu.2017.06.164","volume":"106","author":"K Barami","year":"2017","unstructured":"Barami K, Lyon L, Conell C. Type 2 diabetes mellitus and glioblastoma multiforme-assessing risk and survival: results of a large retrospective study and systematic review of the literature. World Neurosurg. 2017;106:300\u20137. https:\/\/doi.org\/10.1016\/j.wneu.2017.06.164.","journal-title":"World Neurosurg"},{"key":"134_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-106","author":"R Blagus","year":"2013","unstructured":"Blagus R, Lusa L. SMOTE for high-dimensional class-imbalanced data. BMC Bioinf. 2013. https:\/\/doi.org\/10.1186\/1471-2105-14-106.","journal-title":"BMC Bioinf"},{"issue":"6","key":"134_CR4","doi-asserted-by":"publisher","first-page":"e0198581","DOI":"10.1371\/journal.pone.0198581","volume":"13","author":"A Bohn","year":"2018","unstructured":"Bohn A, Braley A, de la Vega PR, Zevallos JC, Barengo NC. The association between race and survival in glioblastoma patients in the US: a retrospective cohort study. PLoS ONE. 2018;13(6):e0198581. https:\/\/doi.org\/10.1371\/journal.pone.0198581.","journal-title":"PLoS ONE"},{"issue":"1","key":"134_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.crad.2019.07.001","volume":"75","author":"T Booth","year":"2020","unstructured":"Booth T, et al. Machine learning and glioma imaging biomarkers. Clin Radiol. 2020;75(1):20\u201332. https:\/\/doi.org\/10.1016\/j.crad.2019.07.001.","journal-title":"Clin Radiol"},{"issue":"11","key":"134_CR6","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1001\/jamaoncol.2016.1373","volume":"2","author":"TJ Brown","year":"2016","unstructured":"Brown TJ, et al. Association of the extent of resection with survival in glioblastoma. JAMA Oncol. 2016;2(11):1460. https:\/\/doi.org\/10.1001\/jamaoncol.2016.1373.","journal-title":"JAMA Oncol"},{"key":"134_CR7","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO, Kegelmeyer WP. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. 2002;16:321\u201357. https:\/\/doi.org\/10.1613\/jair.953.","journal-title":"J Artif Intell Res"},{"issue":"5","key":"134_CR8","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/neuonc\/nox012","volume":"19","author":"W Cheng","year":"2017","unstructured":"Cheng W, Zhang C, Ren X, Wang Z, Liu X, Han S, Wu A. Treatment strategy and IDH status improve nomogram validity in newly diagnosed GBM patients. Neuro-Oncology. 2017;19(5):736\u20138. https:\/\/doi.org\/10.1093\/neuonc\/nox012.","journal-title":"Neuro-Oncology"},{"key":"134_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3978\/j.issn.2224-5820.2015.08.04","volume":"5","author":"S Cheon","year":"2016","unstructured":"Cheon S, et al. The accuracy of clinicians\u2019 predictions of survival in advanced cancer: a review. Ann Palliat Med. 2016;5:22\u20139. https:\/\/doi.org\/10.3978\/j.issn.2224-5820.2015.08.04.","journal-title":"Ann Palliat Med"},{"issue":"1","key":"134_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-014-0241-z","volume":"13","author":"GS Collins","year":"2015","unstructured":"Collins GS, Reitsma JB, Altman DG, Moons K. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC Med. 2015;13(1):1. https:\/\/doi.org\/10.1186\/s12916-014-0241-z.","journal-title":"BMC Med"},{"issue":"5","key":"134_CR11","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.3233\/jifs-169470","volume":"34","author":"DC Corrales","year":"2018","unstructured":"Corrales DC, Lasso E, Ledezma A, Corrales JC. Feature selection for classification tasks: expert knowledge or traditional methods? J Intell Fuzzy Syst. 2018;34(5):2825\u201335. https:\/\/doi.org\/10.3233\/jifs-169470.","journal-title":"J Intell Fuzzy Syst"},{"issue":"5","key":"134_CR12","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1188\/16.cjon.s1.2-8","volume":"20","author":"M Davis","year":"2016","unstructured":"Davis M. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs. 2016;20(5):S2\u20138. https:\/\/doi.org\/10.1188\/16.cjon.s1.2-8.","journal-title":"Clin J Oncol Nurs"},{"key":"134_CR13","doi-asserted-by":"publisher","first-page":"e511","DOI":"10.1016\/j.wneu.2018.08.114","volume":"120","author":"M Fatehi","year":"2018","unstructured":"Fatehi M, Hunt C, Ma R, Toyota BD. Persistent disparities in survival for patients with glioblastoma. World Neurosurg. 2018;120:e511\u20136. https:\/\/doi.org\/10.1016\/j.wneu.2018.08.114.","journal-title":"World Neurosurg"},{"key":"134_CR14","doi-asserted-by":"publisher","first-page":"103089","DOI":"10.1016\/j.jbi.2018.12.003","volume":"90","author":"S Fotouhi","year":"2019","unstructured":"Fotouhi S, Asadi S, Kattan MW. A comprehensive data level analysis for cancer diagnosis on imbalanced data. J Biomed Inform. 2019;90:103089. https:\/\/doi.org\/10.1016\/j.jbi.2018.12.003.","journal-title":"J Biomed Inform"},{"issue":"8","key":"134_CR15","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/nejmoa1308573","volume":"370","author":"MR Gilbert","year":"2014","unstructured":"Gilbert MR, et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma. N Engl J Med. 2014;370(8):699\u2013708. https:\/\/doi.org\/10.1056\/nejmoa1308573.","journal-title":"N Engl J Med"},{"key":"134_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/now208","author":"H Gittleman","year":"2016","unstructured":"Gittleman H, et al. An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG oncology RTOG 0525 and 0825. Neuro-Oncol. 2016. https:\/\/doi.org\/10.1093\/neuonc\/now208.","journal-title":"Neuro-Oncol"},{"key":"134_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/noajnl\/vdz007","author":"H Gittleman","year":"2019","unstructured":"Gittleman H, et al. An independently validated nomogram for isocitrate dehydrogenase-wild-type glioblastoma patient survival. Neuro-Oncol Adv. 2019. https:\/\/doi.org\/10.1093\/noajnl\/vdz007.","journal-title":"Neuro-Oncol Adv"},{"issue":"6","key":"134_CR18","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/annonc\/mdy106","volume":"29","author":"D Gramatzki","year":"2018","unstructured":"Gramatzki D, et al. Bevacizumab may improve quality of life, but not overall survival in glioblastoma: an epidemiological study. Ann Oncol. 2018;29(6):1431\u20136. https:\/\/doi.org\/10.1093\/annonc\/mdy106.","journal-title":"Ann Oncol"},{"issue":"2","key":"134_CR19","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1093\/annonc\/mds341","volume":"24","author":"B Gwilliam","year":"2012","unstructured":"Gwilliam B, Keeley V, Todd C, Roberts C, Gittins M, Kelly L, Barclay S, Stone P. Prognosticating in patients with advanced cancer-observational study comparing the accuracy of clinicians\u2019 and patients\u2019 estimates of survival. Ann Oncol. 2012;24(2):482\u20138. https:\/\/doi.org\/10.1093\/annonc\/mds341.","journal-title":"Ann Oncol"},{"issue":"1","key":"134_CR20","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4103\/2152-7806.132138","volume":"5","author":"DH Harter","year":"2014","unstructured":"Harter DH, Wilson TA, Karajannis MA. Glioblastoma multiforme: state of the art and future therapeutics. Surg Neurol Int. 2014;5(1):64. https:\/\/doi.org\/10.4103\/2152-7806.132138.","journal-title":"Surg Neurol Int"},{"issue":"6","key":"134_CR21","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1001\/jamasurg.2018.0647","volume":"153","author":"AH Kaji","year":"2018","unstructured":"Kaji AH, Rademaker AW, Hyslop T. Tips for analyzing large data sets from the JAMA surgery statistical editors. JAMA Surg. 2018;153(6):508. https:\/\/doi.org\/10.1001\/jamasurg.2018.0647.","journal-title":"JAMA Surg"},{"key":"134_CR22","doi-asserted-by":"publisher","first-page":"e842","DOI":"10.1016\/j.wneu.2018.07.276","volume":"119","author":"AV Karhade","year":"2018","unstructured":"Karhade AV, et al. Development of machine learning algorithms for prediction of 5-year spinal chordoma survival. World Neurosurg. 2018;119:e842\u20137. https:\/\/doi.org\/10.1016\/j.wneu.2018.07.276.","journal-title":"World Neurosurg"},{"issue":"3","key":"134_CR23","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1148\/radiol.2016161382","volume":"281","author":"P Kickingereder","year":"2016","unstructured":"Kickingereder P, et al. Radiogenomics of glioblastoma: machine learning-based classification of molecular characteristics by using multiparametric and multiregional MR imaging features. Radiology. 2016;281(3):907\u201318. https:\/\/doi.org\/10.1148\/radiol.2016161382.","journal-title":"Radiology"},{"key":"134_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s10143-018-01071-3","author":"YJ Kim","year":"2019","unstructured":"Kim YJ, Lee DJ, Park CK, Kim IA. Optimal extent of resection for glioblastoma according to site, extension, and size: a population-based study in the temozolomide era. Neurosurg Rev. 2019. https:\/\/doi.org\/10.1007\/s10143-018-01071-3.","journal-title":"Neurosurg Rev"},{"issue":"1","key":"134_CR25","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3171\/2013.9.jns13788","volume":"120","author":"D Kondziolka","year":"2014","unstructured":"Kondziolka D, et al. The accuracy of predicting survival in individual patients with cancer. J Neurosurg. 2014;120(1):24\u201330. https:\/\/doi.org\/10.3171\/2013.9.jns13788.","journal-title":"J Neurosurg"},{"key":"134_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, et al. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005.","journal-title":"Comput Struct Biotechnol J"},{"issue":"3","key":"134_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1093\/neuonc\/nov127","volume":"18","author":"L Macyszyn","year":"2015","unstructured":"Macyszyn L, et al. Imaging patterns predict patient survival and molecular subtype in glioblastoma via machine learning techniques. Neuro-Oncology. 2015;18(3):417\u201325. https:\/\/doi.org\/10.1093\/neuonc\/nov127.","journal-title":"Neuro-Oncology"},{"issue":"10","key":"134_CR28","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1093\/neuonc\/nos335","volume":"15","author":"MA Mazurowski","year":"2013","unstructured":"Mazurowski MA, Desjardins A, Malof JM. Imaging descriptors improve the predictive power of survival models for glioblastoma patients. Neuro-Oncology. 2013;15(10):1389\u201394. https:\/\/doi.org\/10.1093\/neuonc\/nos335.","journal-title":"Neuro-Oncology"},{"issue":"4","key":"134_CR29","doi-asserted-by":"publisher","first-page":"383","DOI":"10.21037\/tcr.2016.06.31","volume":"5","author":"S Narang","year":"2016","unstructured":"Narang S, Lehrer M, Yang D, Lee J, Rao A. Radiomics in glioblastoma: current status, challenges and potential opportunities. Transl Cancer Res. 2016;5(4):383\u201397. https:\/\/doi.org\/10.21037\/tcr.2016.06.31.","journal-title":"Transl Cancer Res"},{"key":"134_CR30","unstructured":"National Cancer Institute, DCCPS, Surveillance Research Program: Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 18 Regs Custom Data (with additional treatment fields), Nov 2018 Sub (1975-2016 varying) - Linked To County Attributes - Total U.S., 1969-2017 Counties (2019). Based on the November 2018 submission"},{"issue":"17","key":"134_CR31","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1001\/jama.2013.280319","volume":"310","author":"A Omuro","year":"2013","unstructured":"Omuro A. Glioblastoma and other malignant gliomas. JAMA. 2013;310(17):1842. https:\/\/doi.org\/10.1001\/jama.2013.280319.","journal-title":"JAMA"},{"issue":"1","key":"134_CR32","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s11060-016-2217-7","volume":"130","author":"QT Ostrom","year":"2016","unstructured":"Ostrom QT, et al. Completeness of required site-specific factors for brain and CNS tumors in the surveillance, epidemiology and end results (SEER) 18 database (2004\u20132012, varying). J Neurooncol. 2016;130(1):31\u201342. https:\/\/doi.org\/10.1007\/s11060-016-2217-7.","journal-title":"J Neurooncol"},{"key":"134_CR33","doi-asserted-by":"publisher","unstructured":"Ostrom, Q.T., et\u00a0al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the united states in 2011\u20132015. Neuro-Oncology 2018;20(suppl\\_4), iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","DOI":"10.1093\/neuonc\/noy131"},{"key":"134_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2019.1638018","author":"NP Patel","year":"2019","unstructured":"Patel NP, Lyon KA, Huang JH. The effect of race on the prognosis of the glioblastoma patient: a brief review. Neurol Res. 2019. https:\/\/doi.org\/10.1080\/01616412.2019.1638018.","journal-title":"Neurol Res"},{"issue":"2","key":"134_CR35","doi-asserted-by":"publisher","first-page":"E184","DOI":"10.1093\/neuros\/nyz403","volume":"86","author":"JT Senders","year":"2019","unstructured":"Senders JT, et al. An online calculator for the prediction of survival in glioblastoma patients using classical statistics and machine learning. Neurosurgery. 2019;86(2):E184\u201392. https:\/\/doi.org\/10.1093\/neuros\/nyz403.","journal-title":"Neurosurgery"},{"issue":"10","key":"134_CR36","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2217\/fon-2018-0719","volume":"15","author":"C Shu","year":"2019","unstructured":"Shu C, Yan X, Zhang X, Wang Q, Cao S, Wang J. Tumor-induced mortality in adult primary supratentorial glioblastoma multiforme with different age subgroups. Future Oncol. 2019;15(10):1105\u201314. https:\/\/doi.org\/10.2217\/fon-2018-0719.","journal-title":"Future Oncol"},{"issue":"10","key":"134_CR37","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/nejmoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352(10):987\u201396. https:\/\/doi.org\/10.1056\/nejmoa043330.","journal-title":"N Engl J Med"},{"key":"134_CR38","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2019.4213","author":"Y Sun","year":"2019","unstructured":"Sun Y, et al. Characteristics and prognostic factors of age-stratified high-grade intracranial glioma patients: a population-based analysis. Bosnian J Basic Med Sci. 2019. https:\/\/doi.org\/10.17305\/bjbms.2019.4213.","journal-title":"Bosnian J Basic Med Sci"},{"key":"134_CR39","unstructured":"Surveillance Research Program: National Cancer Institute SEER*Stat software (www.seer.cancer.gov\/seerstat) version 8.3.6"},{"issue":"2","key":"134_CR40","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/eva.12524","volume":"11","author":"EVA Sylvester","year":"2017","unstructured":"Sylvester EVA, et al. Applications of random forest feature selection for fine-scale genetic population assignment. Evol Appl. 2017;11(2):153\u201365. https:\/\/doi.org\/10.1111\/eva.12524.","journal-title":"Evol Appl"},{"issue":"6","key":"134_CR41","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1002\/sam.11348","volume":"10","author":"F Tang","year":"2017","unstructured":"Tang F, Ishwaran H. Random forest missing data algorithms. Stat Anal Data Min. 2017;10(6):363\u201377. https:\/\/doi.org\/10.1002\/sam.11348.","journal-title":"Stat Anal Data Min"},{"issue":"10","key":"134_CR42","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1158\/1055-9965.epi-14-0275","volume":"23","author":"JP Thakkar","year":"2014","unstructured":"Thakkar JP, et al. Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomark Prevent. 2014;23(10):1985\u201396. https:\/\/doi.org\/10.1158\/1055-9965.epi-14-0275.","journal-title":"Cancer Epidemiol Biomark Prevent"},{"key":"134_CR43","doi-asserted-by":"publisher","first-page":"e375","DOI":"10.1016\/j.wneu.2018.04.059","volume":"115","author":"P Woo","year":"2018","unstructured":"Woo P, et al. A comparative analysis of the usefulness of survival prediction models for patients with glioblastoma in the temozolomide era: The importance of methylguanine methyltransferase promoter methylation, extent of resection, and subventricular zone location. World Neurosurg. 2018;115:e375\u201385. https:\/\/doi.org\/10.1016\/j.wneu.2018.04.059.","journal-title":"World Neurosurg"},{"key":"134_CR44","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2017.00352","author":"H Xu","year":"2017","unstructured":"Xu H, Chen J, Xu H, Qin Z. Geographic variations in the incidence of glioblastoma and prognostic factors predictive of overall survival in US adults from 2004\u20132013. Frontiers Aging Neurosci. 2017. https:\/\/doi.org\/10.3389\/fnagi.2017.00352.","journal-title":"Frontiers Aging Neurosci."},{"issue":"2","key":"134_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.5213\/inj.2014.18.2.50","volume":"18","author":"C Yoo","year":"2014","unstructured":"Yoo C, Ramirez L, Liuzzi J. Big data analysis using modern statistical and machine learning methods in medicine. Int Neurourol J. 2014;18(2):50. https:\/\/doi.org\/10.5213\/inj.2014.18.2.50.","journal-title":"Int Neurourol J"},{"issue":"1","key":"134_CR46","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/jmri.25497","volume":"46","author":"M Zhou","year":"2016","unstructured":"Zhou M, et al. Identifying spatial imaging biomarkers of glioblastoma multiforme for survival group prediction. J Magn Reson Imaging. 2016;46(1):115\u201323. https:\/\/doi.org\/10.1002\/jmri.25497.","journal-title":"J Magn Reson Imaging"},{"issue":"2","key":"134_CR47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3174\/ajnr.a5391","volume":"39","author":"M Zhou","year":"2017","unstructured":"Zhou M, et al. Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol. 2017;39(2):208\u201316. https:\/\/doi.org\/10.3174\/ajnr.a5391.","journal-title":"Am J Neuroradiol"}],"container-title":["Health Information Science and Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13755-020-00134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13755-020-00134-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13755-020-00134-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T14:17:26Z","timestamp":1638541046000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13755-020-00134-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1007\/s13755-020-00134-4","relation":{},"ISSN":["2047-2501"],"issn-type":[{"value":"2047-2501","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"22 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Analysis of the SEER data does not require an Institutional Review Board approval or informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The code used to generate the above models will be made available upon reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}],"article-number":"5"}}